Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
08/2003
08/07/2003US20030149297 Hydrogenating in presence of rhodium/palladium catalyst, then dehydrating with acetic anhydride; for production of radiation transparent polyimides
08/07/2003US20030149193 Powder coating; to producing coatings having a high crosslinking density and a high level of stability towards weathering and ultraviolet radiation
08/07/2003US20030146419 Photochromic naphthopyran compounds: compositions and articles containing those naphthopyran compounds
08/07/2003CA2473231A1 Resistance-repellent retroviral protease inhibitors
08/06/2003EP1062840A4 Apparatus and method for a custom soft-solid hearing aid
08/06/2003EP1060639A4 Compliant hearing aid and method of manufacture
08/06/2003EP1049537B1 Catalytic compositions and methods for asymmetric allylic alkylation
08/06/2003CN1434826A Method for purifying a composition containing at least an internal dehydration product for a hydrogenated sugar
08/06/2003CN1434047A Calcarisporin B1 and extracting method and use in anti-tumor medicine
08/06/2003CN1117120C Method for recrystallizing diacetal in polyolefin resin
08/05/2003US6603023 Synthesis of epothilones, intermediates thereto and analogues thereof
08/05/2003US6603015 Antitumor agents; anticancer agents; malaria; Alzheimer's disease
08/05/2003US6602903 Substituted heterocyclic compounds
08/05/2003US6602877 Imidazolyl-cyclic acetals
07/2003
07/31/2003WO2003062243A1 Novel compounds as semaphorin inhibitors
07/31/2003WO2003062242A1 Biocidal compounds and their preparation
07/31/2003US20030144533 Synthetic intermediate for epothilone derivative and production method thereof
07/31/2003US20030144523 Epothilone derivatives, method for producing same and their pharmaceutical use
07/31/2003US20030144509 Prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients.
07/31/2003US20030144504 Dialkyl-halogenophenyl-substituted ketoenols
07/31/2003US20030144345 Treatment of metabolic diseases with soraphen derivatives
07/31/2003US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis
07/31/2003US20030144246 Chromenylmethyl pyrimidinediamines as antibacterial agents
07/31/2003US20030140820 Pigmented vitreous material
07/31/2003CA2471749A1 Biocidal compounds and their preparation
07/30/2003EP1330459A2 Triptolide analogs for the treatment of autoimmune and inflammatory disorders
07/30/2003EP1330448A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
07/30/2003CN1116291C Substituted tetracyclic tetrahydrofuran derivatives
07/29/2003US6600062 Enantioselectivity; epoxidizing and hydrolyzing the geranyloxy compound
07/29/2003US6599964 Symmetric substituted benzaldehyde alditol derivatives and compositions and articles containing same
07/29/2003US6599861 Herbicides
07/24/2003WO2003048168A3 Trioxane derivatives as antimalaria or anticancer compounds
07/24/2003WO2002102369A3 Agent for protection of retinal neurons
07/24/2003US20030139612 A nucleating agents for plastic, especially improving the optical properties; food or cosmetic containers and packagings, gelling agents for preparation of antiperspirant gel sticks
07/24/2003US20030139601 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests
07/24/2003US20030139498 Coloring plastics
07/24/2003US20030139460 Antitumor, anticancer agents; antiinflammatory agents; psoriasis; antiarthritic agents; side effect reduction
07/23/2003EP1329452A1 Medicinal compositions, dose and method for treating malaria
07/23/2003EP1086096B1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
07/23/2003EP1079829B1 Use of benzofuroxan derivatives in treating angina pectoris
07/23/2003EP1001957B1 Macrolides with antitumor activity
07/23/2003CN1431212A Similar of sulph DCK, its synthesizing method and applications
07/23/2003CN1431209A Method for synthesizing molluscacide (Al pinumisoflavone) of pyrane isoflavone and its product
07/22/2003US6596873 2-and 2,5-substituted phenylketoenols
07/17/2003WO2003057830A2 Compositions and methods for hydroxylating epothilones
07/17/2003WO2003057700A1 Compositions containing pigmentatin inhibitor, use thereof and process for producing the same
07/17/2003WO2003057685A1 Luminacin analogs and uses thereof
07/17/2003WO2003057173A2 Broad spectrum inhibitors
07/17/2003US20030134883 Use in the treatment of cancer and other diseases characterized by undesired cellular hyperproliferation.
07/17/2003US20030134852 Halogen substituted tetracyclic tetrahydrofuran derivatives
07/17/2003CA2472580A1 Broad spectrum inhibitors
07/17/2003CA2471874A1 Compositions and methods for hydroxylating epothilones
07/16/2003EP1235823B1 H-annellated benzo [f]chromenes
07/16/2003EP1109789B1 Triptolide prodrugs having high aqueous solubility
07/16/2003EP1070069B1 Bicyclic hydroxamic acid derivatives
07/16/2003EP1069121B1 Reagent for singlet oxygen determination
07/16/2003CN1430619A Continuous process for manufacture of anhydro sugar alcohols and reactor used by it
07/16/2003CN1429827A Method for purifying dehydration alditol nd product
07/15/2003US6593479 Coating composition comprising a bicyclo- or spiro-orthoester functional compound
07/10/2003WO2003055871A1 DECAHYDRONAPHTHO[2,3-c]FURAN DERIVATIVES
07/10/2003WO2003055870A1 Fullerene epoxide and process for producing the same
07/10/2003US20030130121 Novel bacterial isolate and the preparation and use of its active metabolites
07/10/2003US20030127933 Coil mold piece, manufacturing method thereof, core, manufacturing method thereof, and rotating machine
07/10/2003US20030127631 Plastic adjuvants; nucleation; radiation transparent
07/09/2003EP1325922A2 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
07/09/2003CN1428324A Process for preparing hydroaromatic polybasic carboxylic acid and process for preparing hydroaromatic polybasic carboxylic anhydride
07/08/2003US6590109 Suspending plant material or extract in presence of oxidation reagent, extracting terpene trilactones using acceptable extraction agent, separating organic layer from aqueous layer to isolate terpene trilactones in organic layer
07/08/2003US6589980 Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
07/08/2003US6589445 Light-reaction type optically active compound, light-reaction type chiral agent, liquid crystal composition, liquid crystal color filter, optical film, recording medium, and method of changing twist structure of liquid crystal
07/03/2003WO2003053977A1 Tetracyclic heterocompounds as estrogen receptor modulators
07/03/2003WO2003053436A1 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
07/03/2003WO2003053435A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
07/03/2003US20030125362 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
07/03/2003US20030121113 Oxobenzofuranylide-dihydroindolone
07/03/2003CA2471107A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
07/03/2003CA2470964A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
07/03/2003CA2469904A1 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
07/02/2003EP1323700A1 process for producing hydrogenated aromatic polycarboxylic acid and process for producing hydrogenated aromatic polycarboxylic anhydride
07/02/2003EP1322307A1 Methods for treating cell proliferative disorders and viral infections
07/02/2003EP1322302A2 Taxoid conjugates as antimitotic and antitumor agents
07/02/2003EP0968983B1 Hexanitrohexaazaisowurtzitane composition and explosive composition containing said composition
07/02/2003CN1427831A Reworkable composition of oxirane (S) or thiirane (S)-containing resin and curing agent
07/02/2003CN1427004A Method of extracting peucedanin from angelica
07/01/2003US6586619 5-norbornene-2-carboxylic acid-3-hydroxyethyl carboxylate for example; far ultraviolet photolithography
07/01/2003US6586464 Artemisinin analogs having antimalarial, antiproliferative, and antitumor activities and chemoselective methods of making the same
06/2003
06/26/2003WO2003051889A1 A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent
06/26/2003WO2003051830A2 Enantiopure 4-deoxypentenosides, dihydropyrans and tetrahydropyrans and syntheses thereof
06/26/2003WO2003051303A2 The total synthesis of merrilactone a
06/26/2003US20030120093 Reacting cytotoxic hydrofuranoxanthones with palladium complex and benzoquinone in presence of dimethyl sulfoxide; antiproliferative/antitumor agents; topoisomerase inhibitors; downregulating oncogenes
06/26/2003US20030120092 Reaction product mixtures including both symmetric compounds and asymmetric dipolar multi-substituted alditol derivatives
06/26/2003US20030120024 Polyester polycarbonates of particular diphenols
06/26/2003US20030119931 Photopolymerizable mixtures of a vinyl ether, photoinitiator system of an iodonium salt, a visible light sensitizer, and electron donor compound, and optional spiroorthocarbonates, epoxides, polyols; e.g. dental composites
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030118877 New electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators
06/26/2003US20030118678 Plant extracts as antiproliferative, viricides and antiparasitic agents
06/26/2003CA2470009A1 The total synthesis of merrilactone a
06/26/2003CA2469879A1 A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent
06/25/2003CN1426415A Fluorescent compounds
06/25/2003CN1425667A New compound with anti-tumor function, its preparing method and use in preparing medicine for curing tumor
06/24/2003US6583319 Cyclic compounds having a cycloalkylene chain
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 174